Status:

COMPLETED

Comparison of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks With Sofosbuvir and Ribavirin for 12 Weeks in Adults With Chronic Genotype 2 HCV Infection

Lead Sponsor:

Gilead Sciences

Conditions:

Hepatitis C Virus Infection

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

The primary objectives of this study are to evaluate the efficacy, safety, and tolerability of treatment with sofosbuvir/velpatasvir (SOF/VEL) fixed-dose combination (FDC) for 12 weeks compared to tre...

Eligibility Criteria

Inclusion

  • Willing and able to provide written informed consent
  • HCV RNA ≥ 10\^4 IU/mL
  • HCV genotype 2
  • Chronic HCV infection (≥ 6 months)
  • Females of childbearing potential must have a negative serum pregnancy test
  • Males and females of childbearing potential who engage in heterosexual intercourse must agree to use protocol specified method(s) of contraception
  • Must be of generally good health, with the exception of chronic HCV infection, as determined by the investigator.

Exclusion

  • Current or prior history of clinically-significant illness (other than HCV that may interfere with treatment, assessment or compliance with the protocol;
  • Screening electrocardiogram (ECG) with clinically significant abnormalities
  • Laboratory results outside of acceptable ranges at Screening
  • Pregnant or nursing female or male with pregnant female partner
  • Chronic liver disease of a non-HCV etiology (e.g., hemochromatosis, Wilson's disease, alfa-1 antitrypsin deficiency, cholangitis)
  • Infection with hepatitis B virus (HBV) or human immunodeficiency virus (HIV)

Key Trial Info

Start Date :

September 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2015

Estimated Enrollment :

269 Patients enrolled

Trial Details

Trial ID

NCT02220998

Start Date

September 1 2014

End Date

September 1 2015

Last Update

November 15 2018

Active Locations (51)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 13 (51 locations)

1

Long Beach, California, United States, 90822

2

Los Angeles, California, United States, 90027

3

Los Angeles, California, United States, 90036

4

Los Angeles, California, United States, 90048